Department: Pediatrics

Division: Human Gene Therapy

• Faculty (3)
• Postdocs (0)
• All

• 
  Kay, Mark 
  Academic Appointments

  • Professor, Pediatrics - Human Gene Therapy
  • Professor, Genetics
  • Member, Bio-X
  • Member, Cancer Center
  Research Interest

  Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.

• 
  Lin, Michael Z
  Academic Appointments

  • Acting Assistant Professor, Pediatrics - Human Gene Therapy
  Research Interest

  Our lab applies biochemical and engineering principles to the development of protein-based tools for molecular imaging and gene therapy. Topics of investigation include fluorescent proteins structure and biophysics, fluorescent protein-based biosensors, spatiotemporal analysis of protein translation pathways, chemical control of protein translation, and light-responsive proteins.

• 
  Mellins, Elizabeth D
  Academic Appointments

  • Associate Professor - Med Center Line, Pediatrics - Human Gene Therapy
  • Member, Bio-X
  Clinical Focus

  • Pediatric Rheumatology
  • Rheumatology, Pediatric
  Research Interest

  Molecular mechanisms and intracellular pathways of antigen processing and presentation; structure/function of HLA-DR,-DM, -DO; HLA allele association with disease; pathogen evasion of the class II pathway.

  Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital